John F. Cogan, PhD
Lead Independent Director, Gilead Sciences

John F. Cogan, PhD joined Gilead’s Board of Directors in July 2005 and was appointed Lead Independent Director in May 2013. Dr. Cogan is currently the Leonard and Shirley Ely Senior Fellow at the Hoover Institution at Stanford University. Dr. Cogan’s current research is focused on U.S. budget and fiscal policy, health care and social security. Dr. Cogan has held a number of positions in the U.S. government, including Assistant Secretary for Policy in the U.S. Department of Labor and Associate Director and Deputy Director in the U.S. Office of Management and Budget. Dr. Cogan is a trustee of the Charles Schwab Family of Funds.

NASDAQ (US Dollar)
$67.57
 Stock is Down 0.44 (0.65%)
Data as of 11/20/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Third Quarter 2018 Gilead Sciences Earnings Conference Call

October 25, 2018 4:30 p.m. ET
Play
Gilead Sciences at the Morgan Stanley 16th Annual Global Healthcare Conference

September 12, 2018 11:05 a.m. ET
Play
Second Quarter 2018 Gilead Sciences Earnings Conference Call

July 25, 2018 2:00 p.m. PT
Play
Gilead Sciences at the Goldman Sachs 39th Annual Global Healthcare Conference

June 13, 2018 8:40 a.m. PT
Play